NCT05601960

A Combination Treatment Reduces Acne Severity and PIHP

A Combination of a Dermocosmetic and a Tainted Sunscreen Reduce Acne Severity and Signs of Post-inflammatory Hyperpigmentation in Subjects With a Fitzpatrick Phototype Ranging From IV to VI

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,785 (actual)
• Sponsor: Cosmetique Active International · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

Acne is a chronic, inflammatory skin condition. It may cause scars and post-inflammatory hyperpigmentation (PIHP). PIHP frequently affects individuals with a phototype of IV or above.\[1\] PIHP is worsened by UV radiation, lasts for years and impacts the individual well-being.\[2, 3\] In an observational study, 1785 adults with a phototype ranging from IV to VI with acne and PIHP applied daily for 2 months a dermocosmetic and a tainted sunscreen product (DC, Effaclar® Duo (+); SS, Anthelios® Shaka Fluide SPF 50+, SS; both La Roche-Posay Laboratoire Dermatologique, France.

Conditions

• Acne
• Postinflammatory Hyperpigmentation

Interventions

Type	Name	Description
OTHER	anti-acne dermocosmetic	Topical application once daily for 2 months

Timeline

• Start date: 2020-04-15
• Primary completion: 2021-02-28
• Completion: 2021-02-28
• First posted: 2022-11-01
• Last updated: 2022-11-01

Locations

1 site across 1 country: United Arab Emirates